Human Study of Functional Meat Products
Nutritional Intervention Study to Evaluate the Effect of an Olive Oil Lipid Rich in Diglycerides as a Fat Replacement in Different Meat Products, in a Healthy Population
調査の概要
詳細な説明
Different studies have revealed that many chronic pathologies including cardiovascular disease, diabetes, autoimmune disorders, cancer, obesity or neurological diseases, could be influenced by different dietary components, such as lipids. Thus, looking for ways to substitute healthier lipids for fats that contain high amounts of cholesterol, saturated fatty acids or trans fat, could be of great interest in the prevention of chronic diseases.
Currently, meat and meat products, especially those where the fat is one of the main ingredients of the formulation, are perceived as unhealthy foods associated with increased risk of cardiovascular disease, cancer and obesity development. This is mainly due to their content of fat, trans fat, high percentage of saturated fatty acids, and cholesterol. Examples include sausages, meat spreads, salami or mortadella. Interestingly, despite the negative perception, meat and meat products continue to hold a relevant position in the diet of the developed countries. Indeed, the group "meat, poultry, deli meats and offal" contribute to the 17% of the total dietary fat intake of the Spanish population. Moreover, the consumption of deli meats and other meat products represents 5.8% of the total caloric intake. These values support the increased interest in evaluating the effect of improving the composition of these products in the prevention of disease.
Overweight and obesity are main public health concerns worldwide. They both contribute to the development of numerous diseases increasing the morbidity and mortality rates of the adult population. In this context, it is suggested that the incorporation of healthier fats may be of great interest in the prevention of these conditions. Thus, usage of lipids from olive oil as fats replacements in meat products could be an interesting strategy for the prevention and treatment of overweight and obesity.
A randomized, controlled, nutritional intervention is proposed to evaluate the effect of functional meat products on body composition and lipid profile in healthy individuals.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Madrid、スペイン、28049
- Imdea-Food
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Men and women between 18 - 65 years old.
- BMI >20<27
- Adequate education level and comprehension of the clinical study.
- Willingness to participate in the study as a volunteer and to provide written consent.
Exclusion Criteria:
- Diagnosis of Type I Diabetes .
- BMI >27
- Dyslipidemia under pharmacological treatment.
- High blood pressure.
- Dementia, neurological disease or reduction of cognitive function.
- Severe illness (hepatic disease, renal disease, etc.).
- Refusal to consume the experimental or control meat products (e.g. Vegetarians)
- Refusal to follow healthy eating guidelines.
- Taking medications that could affect the lipid and glycemic profiles (statins, fibrate, diuretics, corticoids, anti-inflammatory, hypoglucemic or insulin) 30 days before the beginning of the study.
- Taking medications or substances for weight loss management (15 days before the beginning of the study).
- Consideration to follow a weight loss diet during the duration of the study.
- Pregnancy or lactation.
- High intake of alcohol.
- Any other exclusion criteria that the main investigator considers relevant.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Functional meat products with healthy lipids from olive oil
Healthy people consuming 300g/week of functional meat products with high diglyceride lipid from olive oil
|
|
|
プラセボコンパレーター：Traditional meat products
Healthy people consuming the same amount of traditional meat products
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in waist circumference
時間枠：Before and after 8 weeks
|
The waist circumference (WC) was measured using a Seca 201 inelastic tape (Quirumed, Valencia, Spain).
|
Before and after 8 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in lipid profile
時間枠：Before and after 8 weeks
|
To evaluate lipid improvements the following measurements will be taking into account:
|
Before and after 8 weeks
|
|
Changes in fat depots
時間枠：Before and after 8 weeks
|
To evaluate changes in fat depots leptin levels will be measured
|
Before and after 8 weeks
|
|
Changes in blood clotting and endothelial function
時間枠：Before and after 8 weeks
|
To evaluate changes in blood clotting and endothelial function will be taken into account:
|
Before and after 8 weeks
|
|
Product safety
時間枠：Before and after 8 weeks
|
To con trol the safety of the products the following variables will be measured:
|
Before and after 8 weeks
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Nagao T, Watanabe H, Goto N, Onizawa K, Taguchi H, Matsuo N, Yasukawa T, Tsushima R, Shimasaki H, Itakura H. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial. J Nutr. 2000 Apr;130(4):792-7. doi: 10.1093/jn/130.4.792.
- Pearson AM. (1997). Principles and applications in production of reduced and low fat products. In: Production and processing of healthy meat, poultry and fish products. Advances in meat research. Vol 11. Pearson AM, Dutson TR (Eds). Blackie Academic & Professional
- Rudkowska I, Roynette CE, Demonty I, Vanstone CA, Jew S, Jones PJ. Diacylglycerol: efficacy and mechanism of action of an anti-obesity agent. Obes Res. 2005 Nov;13(11):1864-76. doi: 10.1038/oby.2005.229.
- Saito S, Yamaguchi T, Shoji K, Hibi M, Sugita T, Takase H. Effect of low concentration of diacylglycerol on mildly postprandial hypertriglyceridemia. Atherosclerosis. 2010 Dec;213(2):539-44. doi: 10.1016/j.atherosclerosis.2010.07.062. Epub 2010 Aug 19.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- IMD PI014
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。